ILLR · Triller Group Inc.

Triller Group Inc. faces a significant regulatory challenge following the receipt of a delisting determination letter from Nasdaq on April 17, 2026. The determination cites the Company's failure to satisfy the Minimum Bid Price Requirement (Nasdaq Listing Rule 5550(a)(2)) as of December 29, 2025. The Company had previously received a deficiency notice on June 30, 2025, granting a standard 180-day cure period to regain compliance by maintaining a closing bid price of at least $1.00 per share for 10 consecutive business days. The Company failed to meet this threshold by the December 29, 2025 deadline and was rendered ineligible for a second 180-day cure period.

The procedural history is complex. While trading was suspended from December 30, 2025, to April 15, 2026, due to non-compliance with the Periodic Filing Rule, the Listing Council modified previous decisions to allow trading to resume after the Company filed its Form 10-K. However, the Staff issued the bid price delisting determination shortly after trading resumed. The Listing Council intervened on April 21, 2026, remanding the matter to the Hearings Panel. Crucially, the Listing Council signaled that if the Hearings Panel agrees with the Staff's view that the Company is ineligible for further cure time and issues a delisting decision, the Council will call the matter for review and stay the delisting. This provides a potential, though uncertain, pathway for the Company to argue for additional time to regain compliance. The Company intends to submit a response to the Hearings Panel on April 24, 2026, requesting a new exception period under Nasdaq Listing Rule 5815(c)(1)(A).